- Home
- CCK vs ASND Comparison
CCK vs ASND Comparison
Compare CCK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCK | ASND |
|---|---|---|
| Founded | 1906 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 15.0B |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CCK | ASND |
|---|---|---|
| Price | $116.61 | $245.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 22 |
| Target Price | $136.15 | ★ $304.69 |
| AVG Volume (30 Days) | ★ 781.4K | 671.6K |
| Earning Date | 10-19-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | ★ 79.72 | N/A |
| EPS | ★ 3.78 | N/A |
| Revenue | ★ $11,665,000,000.00 | N/A |
| Revenue This Year | $13.34 | $90.79 |
| Revenue Next Year | $2.39 | $46.19 |
| P/E Ratio | $30.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $91.31 | $188.07 |
| 52 Week High | $122.91 | $282.15 |
Technical Indicators
Market Signals| Indicator | CCK | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 61.64 |
| Support Level | $113.11 | $240.10 |
| Resistance Level | $122.11 | $249.89 |
| Average True Range (ATR) | 2.64 | 5.76 |
| MACD | 0.91 | 3.17 |
| Stochastic Oscillator | 74.01 | 97.58 |
Price Performance
Historical ComparisonAbout CCK Crown Holdings Inc.
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.